Laser Photocoagulation of Communicating Vessels in Twin-to-Twin Transfusion Syndrome
Recruiting
Observational Study
Twin to Twin Transfusion as Antepartum Condition
Monochorionic Diamniotic Placenta
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Female
- Study type
- Observational
- Participants needed
- 2,000 (estimated)
- Sponsor
- Seattle Children's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the use of diode laser photocoagulation of the communicating vessels in twin-to- twin transfusion syndrome (TTTS) with respect to maternal, fetal and neonatal outcomes.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Single placenta (Monochorionic)
* Polyhydramnios present in recipient twin (Greater than 8 cm maximum vertical pocket below 20 weeks and greater than a 10 cm pocket for greater than 20 weeks gestational age)
* Oligohydramnios present in donor twin (Less than 2 cm maximum verti…
Contacts